Overview
Luc Friboulet practices practicing medicine in Villejuif, France.
Mr. Friboulet is highly rated in 5 conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, PIK3CA-Related Overgrowth Spectrum, and Tissue Biopsy.
He is actively involved in clinical research, co-authoring 78 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Luc Friboulet
Is Luc Friboulet a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Luc Friboulet is classified as an Distinguished expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Luc Friboulet participate in research or clinical trials?
Yes. Luc Friboulet has published 78 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Luc Friboulet's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerMr. Friboulet isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung CancerMr. Friboulet isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Friboulet isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- PIK3CA-Related Overgrowth SpectrumMr. Friboulet isAdvanced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Tissue BiopsyMr. Friboulet isAdvanced. Learn about Tissue Biopsy.
- Experienced
- Anaplastic Large Cell LymphomaMr. Friboulet isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Cholangiocarcinoma (Bile Duct Cancer)Mr. Friboulet isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- EGFR Positive Lung CancerMr. Friboulet isExperienced. Learn about EGFR Positive Lung Cancer.
- Li-Fraumeni SyndromeMr. Friboulet isExperienced. Learn about Li-Fraumeni Syndrome.
- Lung AdenocarcinomaMr. Friboulet isExperienced. Learn about Lung Adenocarcinoma.
- Medullary Thyroid CarcinomaMr. Friboulet isExperienced. Learn about Medullary Thyroid Carcinoma.
- Neuroendocrine TumorMr. Friboulet isExperienced. Learn about Neuroendocrine Tumor.
- Prostate CancerMr. Friboulet isExperienced. Learn about Prostate Cancer.
- Squamous Cell Carcinoma of the Anal Canal (SCAC)
- T-Cell LymphomaMr. Friboulet isExperienced. Learn about T-Cell Lymphoma.
- Urothelial CancerMr. Friboulet isExperienced. Learn about Urothelial Cancer.